title: [Detection of asymptomatic HBV infection among pregnant women based on personal studies].
abstract: The total seroprevalence of HBsAg among pregnant women in Gdańsk region is 1.3%. Our examination was based on observation of 226 HBsAg chronic carrier pregnant women. The risk of infection on the way of inoculation in childhood took place in 68%, in 10.8% it was connected with occupation. The presence of HBsAg and HBeAg was revealed in 8.8%. During period of observation none of the women eliminated HBsAg. The clinical course of infection in our group was stable. Liver biopsy was performed in 47 cases. Hepatitis minimalis was found in 35 cases, fibrosis portalis in 2, hepatitis chronica persistens in 5 and normal histological liver structure in 2 cases. Asymptomatic carrier state didn't influence on the course of pregnancy and delivery.
authors.affiliation: Klinika Chorób Zakaźnych Instytutu Chorób Wewnetrznych Akademii Medycznej Gdańsku.
authors.forename: Z
authors.initials: Z
authors.lastname: Michalska
authors.forename: D
authors.initials: D
authors.lastname: Radowska
authors.forename: J
authors.initials: J
authors.lastname: Stolarczyk
authors.forename: M
authors.initials: M
authors.lastname: Własiuk
authors.forename: D
authors.initials: D
authors.lastname: Michalik
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D011044:Poland / Q000453:epidemiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D014505:Urban Population
chemical_list: D015415:Biomarkers; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens
vernacular_title: Bezobjawowe zakazenie HBV w populacji kobiet ciezarnych na podstawie własnych badań.